Our observation that EA11 inhibits breast cancer cell migration/invasion and interferes with the activation of the FAK/ERK/NF-κB signaling pathway indicates that EA11 may be an active agent against bone metastasis of breast cancer cells. Here, MAPK1 is linked to breast carcinoma.